Skip to main content

Camp4 Therapeutics Corp

CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001736730

In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Camp4 Therapeutics Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CAMP: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders3929−10
Shares12.7M11.7M−932.9K (−7.4%)
Value$50.7M$17.0M−$33.7M (−66.4%)

New holders (7)

Institutions that held Camp4 Therapeutics Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CAMP in Q2 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC133,036$192.9K0.00%
Bridgeway Capital Management, LLC25,000$36.3K0.00%
Qube Research & Technologies Ltd14,871$21.6K0.00%
Verition Fund Management LLC14,760$21.4K0.00%
Cantor Fitzgerald, L. P.12,320$17.9K0.00%
Tower Research Capital LLC (TRC)3,830$5.55K0.00%
SBI Securities Co., Ltd.20$290.00%

Sold out (17)

Institutions that held Camp4 Therapeutics Corp at the end of Q1 2025 and filed for Q2 2025 without it.